DAP - death associated protein Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101090169
DAP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_003981544.6 | XP_003981593.1 | death-associated protein 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
death-associated protein 1 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P10375 | BMS-986189 | Inhibitor | 99.58% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(85)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-100714A | D-AP5 | Antagonist | 99.94% | Unkown |
| HY-P1070 | Amylin, amide, human | 98.33% | Unkown | |
| HY-P4931 | Mca-KPLGL-Dap(Dnp)-AR-NH2 | 99.30% | Unkown | |
| HY-P1070A | Amylin, amide, human TFA | 98.76% | Unkown | |
| HY-W010922 | Fmoc-Dap(Boc)-OH | 99.98% | Unkown | |
| HY-175510 | TREM2 agonist-5 | Agonist | 99.61% | Unkown |
| HY-W010962 | Fmoc-Dap(Alloc)-OH | 99.84% | Unkown | |
| HY-78932A | Dap-NE hydrochloride | 99.99% | Unkown | |
| HY-78931 | Boc-Dap-NE | 99.96% | Unkown | |
| HY-P10086 | TREM-1 inhibitory peptide GF9 | Inhibitor | 99.41% | Unkown |
| HY-P10950A | PD-L1 inhibitory peptide TFA | Inhibitor | 99.81% | Unkown |
| HY-400913 | Mal-L-Dap(Boc, t-BuOAc)-OH | 95.20% | Unkown | |
| HY-P5524A | C12-iE-DAP hydrochloride | Agonist | 96.59% | Unkown |
| HY-W008325 | Boc-L-Dap-OH | 98.0% | Unkown | |
| HY-W047799 | Boc-Dap(Boc)-OH | 98.0% | Unkown | |
| HY-P5523A | iE-DAP dihydrochloride | 99.72% | Unkown | |
| HY-144022 | 16:0 DAP | 99% | Unkown | |
| HY-W046355 | Fmoc-D-Dap(Boc)-OH | 99.56% | Unkown | |
| HY-138169 | Fmoc-Dap(Mtt)-OH | / | Unkown | |
| HY-151715 | N3-D-Dap(Fmoc)-OH | 99.96% | Unkown | |
| HY-164170 | Photocaged DAP | 98.13% | Unkown | |
| HY-W250408 | Fmoc-NMe-Val-Val-Dil-Dap-OH | 96.19% | Unkown | |
| HY-160795 | Boc-NMe-Val-Val-Dil-Dap-OH | 97.54% | Unkown | |
| HY-W014692 | Boc-D-2,3-diaminopropionic acid | ≥97.0% | Unkown | |
| HY-78931A | (R,S,S,R,S)-Boc-Dap-NE | 97.13% | Unkown | |
| HY-P4905 | Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 | Inhibitor | 98.02% | Unkown |
| HY-78932G | Dap-NE hydrochloride (GMP) | / | Unkown | |
| HY-130961 | Boc-Val-Dil-Dap-OH | 98.52% | Unkown | |
| HY-145800 | Photocaged DAP TFA | 99.86% | Unkown | |
| HY-151640 | Fmoc-DAP-N3 | / | Unkown | |
| HY-P3120 | Mca-Pro-Leu-Ala-Cys(Mob)-Trp-Ala-Arg-Dap(Dnp)-NH2 | Substrate | 96.30% | Unkown |
| HY-78931B | (S,S,S,S,R)-Boc-Dap-NE | 99.80% | Unkown | |
| HY-78931C | (S,S,R,S,R)-Boc-Dap-NE | 99.78% | Unkown | |
| HY-78931E | (R,S,R,S,R)-Boc-Dap-NE | 98.74% | Unkown | |
| HY-78931F | (R,S,S,S,R)-Boc-Dap-NE | 99.56% | Unkown | |
| HY-78932 | Dap-NE | 99.49% | Unkown | |
| HY-78932C | (2S,3R)-Dap-NE hydrochloride | Inhibitor | / | Unkown |
| HY-78931G | Boc-Dap-NE (GMP) | / | Unkown | |
| HY-100714B | L-AP5 | Antagonist | / | Unkown |
| HY-100781 | D-AP4 | Antagonist | / | Unkown |
| HY-118316 | GSK223 | Inhibitor | / | Unkown |
| HY-121634 | DAP-81 | Inhibitor | / | Unkown |
| HY-130975 | Boc-Val-Dil-Dap-Phe-OMe | / | Unkown | |
| HY-130976 | N-Boc-Val-Dil-Dap-Doe | / | Unkown | |
| HY-143700 | 18:0 DAP | 99.99% | Unkown | |
| HY-144020 | 14:0 DAP | / | Unkown | |
| HY-148760 | SGD-1882-Dap-Val | / | Unkown | |
| HY-154981 | Mal-L-Dap(Boc)-OSu | / | Unkown | |
| HY-164787 | N-MeVal-Val-Dil-Dap-2-(pyridin-3-yl)ethanamine | Inhibitor | / | Unkown |
| HY-179254 | Mal-L-Dap(Boc, t-BuOAc)-Pfp Ester | / | Unkown | |
| HY-180692 | (S)-2-Acetamido-6-oxopimelic acid | / | Unkown | |
| HY-184530A | Flotufolastat Ga | / | Unkown | |
| HY-P10775 | BT1769 | Antagonist | / | Unkown |
| HY-P10950 | PD-L1 inhibitory peptide | Inhibitor | / | Unkown |
| HY-P11249 | Mr1.1[S4Dap, C16Pen] | Inhibitor | / | Unkown |
| HY-P11330 | L-Ala-D-Glu-m-DAP-D-Ala-D-Ala | / | Unkown | |
| HY-P1274 | ShK-Dap22 | Inhibitor | / | Unkown |
| HY-P3098 | Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2 | / | Unkown | |
| HY-P3120A | Mca-Pro-Leu-Ala-Cys(Mob)-Trp-Ala-Arg-Dap(Dnp)-NH2 TFA | Substrate | / | Unkown |
| HY-P3477 | Mca-PLA-Nva-Dap(Dnp)-AR-NH2 | / | Unkown | |
| HY-P4931A | Mca-KPLGL-Dap(Dnp)-AR-NH2 TFA | / | Unkown | |
| HY-P5523 | iE-DAP | / | Unkown | |
| HY-P5524 | C12-iE-DAP | Agonist | / | Unkown |
| HY-RS03525 | DAP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS03526 | DAP3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS03914 | DNPEP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS06506 | IAPP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W109214 | Fmoc-L-Dap(Boc,Me)-OH | / | Unkown | |
| HY-W337644 | Fmoc-L-Homoarg(Et)2-OH hydrochloride | / | Unkown | |
| HY-107719 | D-AP7 | / | Unkown | |
| HY-151736 | N3-L-Dap(Boc)-OH | / | Unkown | |
| HY-151780 | Fmoc-L-Dap(Pentynoyl)-OH | / | Unkown | |
| HY-151781 | Fmoc-L-Dap(Poc)-OH | / | Unkown | |
| HY-151849 | Z-L-Dap(N3)-OH | / | Unkown | |
| HY-162819 | Apoptosis inducer 26 | Inducer | / | Unkown |
| HY-164867 | Fmoc-L-Dap(NBSD)-OH | / | Unkown | |
| HY-177991 | Cylic-DAP | / | Unkown | |
| HY-177992 | Cyclic-di-DAP | / | Unkown | |
| HY-179828 | DLin-C-DAP | / | Unkown | |
| HY-78932D | (2R,3R)-Dap-NE hydrochloride | Inhibitor | / | Unkown |
| HY-RS16934 | Dap Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17689 | Iapp Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21319 | Dap3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23377 | Dap Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27838 | Dap3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991220 | AL002 | Agonist | 98.01% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service